Skip to content

Clinical trials

Phase 2 Diabetes Mellitus trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 2 Country / region: United States Clear all

280 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20018
20024
200311
20046
20056
200615
200719
200825
200914
201020
201115
201215
201312
201413
201515
20165
201711
20189
20196
202010
202110
20224
20238
20242
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed192
Terminated44
Recruiting14
Withdrawn12
Unknown status7
Active, not recruiting6
Not yet recruiting2
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)18
AstraZeneca11
Novo Nordisk A/S8
GlaxoSmithKline6
Massachusetts General Hospital6
Eli Lilly and Company5
Novartis Pharmaceuticals5
Albert Einstein College of Medicine4
Mayo Clinic4
Pfizer4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus280
Diabetes Mellitus, Type 274
Diabetes Mellitus, Type 134
Obesity30
Insulin Resistance27
Diabetic Neuropathies15
Diabetic Retinopathy15
Glucose Metabolism Disorders15
Diabetic Nephropathies12
Hypertension12

Trials

Showing 1 to 25 of 280. Each trial links to its page on Pharma Observatory.

180 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.